Evaluation of cardiac MRI parameters during mavacamten treatment in obstructive hypertrophic cardiomyopathy: three- and six-month results
Event:
Heart Failure 2025
Topic:
Hypertrophic Cardiomyopathy
Session:
ePosters in myocardial disease - hypertrophic cardiomyopathy (3)